Stockscreener 앱 받기
77.99
2.80%
-2.25
시장 영업 전:
77.37
-0.62
-0.79%
Lantheus Holdings Inc 주식(LNTH)의 최신 뉴스
How Lantheus Holdings Inc. (LNTH) Affects Rotational Strategy Timing - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lantheus Holdings, Inc. (LNTH) And Encourages Investors to Connect - ACCESS Newswire
Aug Weekly: Will Lantheus Holdings Inc outperform the market in YEAR2026 Key Highlights & Scalable Portfolio Growth Methods - baoquankhu1.vn
Why Lantheus Holdings Stock Popped by Almost 12% Last Month - AOL.com
Lantheus price target raised to $82 from $80 at Truist - MSN
Lantheus says FDA extended review period for radioactive diagnostic kit - Seeking Alpha
Citizens reiterates Lantheus stock rating after FDA extends review By Investing.com - Investing.com Canada
FDA extends review of Lantheus’ neuroendocrine tumor drug By Investing.com - Investing.com South Africa
Lantheus says FDA pushed deadline for reviewing its tumor diagnostic kit application - MSN
Lantheus Holdings, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Lantheus stock holds Outperform at William Blair after FDA delay - Investing.com
Lantheus stock holds Outperform at William Blair after FDA delay By Investing.com - Investing.com UK
Lantheus Says FDA Pushed Deadline For Reviewing Its Tumor Diagnostic Kit Application - Asianet Newsable
Lantheus (LNTH) Drug Application Review Extended by FDA - GuruFocus
Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs) - Bitget
Jefferies Maintains Buy on Lantheus Holdings (LNTH) Mar 17 2026 - Meyka
US FDA extends review of Lantheus' diagnostic imaging kit by three months - Yahoo Finance
FDA extends review of Lantheus’ neuroendocrine tumor drug - Investing.com
Bronstein, Gewirtz & Grossman, LLC Encourages Lantheus Holdings, Inc. (LNTH) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Jefferies raises Lantheus stock price target on PSMA PET outlook By Investing.com - Investing.com Canada
Lantheus Holdings Inc Stock (ISIN: US5156731020) Faces Pressure as Farallon Sells 3.245 Million Shar - AD HOC NEWS
Farallon Capital Management LLC Sells 3,245,000 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lantheus Holdings, Inc. (LNTH) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2026-03-15 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lantheus Holdings, Inc. (LNTH) and Encourages Investors to Learn More About the Investigation | NDAQ:LNTH | Press Release - Stockhouse
Lantheus Holdings, Inc. (NASDAQ:LNTH) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Lantheus (NASDAQ:LNTH) Lowered to Buy Rating by Wall Street Zen - MarketBeat
How does Lantheus Holdings Inc compare to its peersLayoff News & Community Consensus Trade Alerts - baoquankhu1.vn
FDA approves Lantheus’ PYLARIFY TruVu for prostate cancer imaging - Investing.com Nigeria
Portolan Capital Management LLC Purchases 42,731 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus Secures Two FDA Milestones in Four Days: Lutathera Radioequivalent and PSMA PET Upgrade - Oncodaily
Lantheus Holdings (LNTH) Is Up 5.4% After New PYLARIFY TruVu And LUTATHERA ApprovalsHas The Bull Case Changed? - simplywall.st
Why Lantheus (LNTH) Is Up 5.4% After Dual FDA Wins In Radiopharmaceutical Oncology Expansion - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lantheus Holdings, Inc. (LNTH) And Encourages Stockholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lantheus Holdings, Inc. (LNTH) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Lantheus Stock Analysis: 57% Gain Amid Revenue and Margin ConcernsNews and Statistics - IndexBox
LNTH Stock Price, Quote & Chart | LANTHEUS HOLDINGS INC (NASDAQ:LNTH) - ChartMill
Imaging & Diagnostics Stocks Decline After Q4 2025 EarningsNews and Statistics - IndexBox
Q4 Earnings Highlights: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & SuppliesImaging, Diagnostics Stocks - Yahoo Finance
WINTON GROUP Ltd Grows Position in Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus at Leerink Conference: Strategic Shifts and Challenges - Investing.com Nigeria
LNTH: Transition to new radiodiagnostics and operational focus set up for growth in 2026 and beyond - TradingView
Why Lantheus Holdings stock popped by almost 12% last month - MSN
Lantheus (LNTH) officer gets 36,692 stock units, with tax share disposal - Stock Titan
Lantheus (LNTH) awards 20,966 RSUs and PSUs to executive Dinkelborg - Stock Titan
Lantheus Holdings (LNTH) CFO receives 38,002-share stock award, tax shares withheld - Stock Titan
Lantheus Holdings (LNTH) CAO reports 6,158-share grant and 133-share tax withholding - Stock Titan
Lantheus Holdings Inc (LNTH) Stock Price Up 7.21% on Mar 9 - GuruFocus
Lantheus (NASDAQ:LNTH) Trading 7.2% HigherTime to Buy? - MarketBeat
Citizens reiterates Lantheus stock rating on royalty opportunities By Investing.com - Investing.com Canada
Why Is LNTH Stock Up After Hours? - Stocktwits
(LNTH) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lantheus Holdings, Inc. (LNTH) And Encourages Investors to Reach Out - ACCESS Newswire
Lantheus drops as Truist downgrades after Q2 miss - MSN
2026-03-08 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lantheus Holdings, Inc. (LNTH) And Encourages Investors to Reach Out | NDAQ:LNTH | Press Release - Stockhouse
FDA approves Lantheus’ PYLARIFY TruVu for prostate cancer imaging By Investing.com - Investing.com Australia
Lantheus Holdings Q1 2025 Earnings Preview - MSN
Teachers Retirement System of The State of Kentucky Reduces Stake in Lantheus Holdings, Inc. $LNTH - MarketBeat
Wall Street Zen Upgrades Lantheus (NASDAQ:LNTH) to Strong-Buy - MarketBeat
American Century Companies Inc. Sells 341,642 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat
2.02%
0.77%
자본화:
|
볼륨(24시간):